ConvaTec Group PLC banner

Intrinsic Value

The intrinsic value of ConvaTec Group PLC (2CV) under the Base Case is 2.58 EUR per share. Compared with the current market price of 2.84 EUR, the stock appears Overvalued by 9% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

2CV Intrinsic Value
€2.58
Overvaluation 9%
Intrinsic Value
Price €2.84
Alert me when 2CV is below its intrinsic value
Today €2.07 · 27.2% below the current price

2CV is cheaper than usual. Still overvalued, but less so than on 87% of days in the past 5 years.

Alternatives to 2CV

Fundamental Analysis

What ConvaTec Group Does

Health Care

ConvaTec Group PLC makes medical products used to care for people with long-term or chronic conditions. Its main products include ostomy bags and accessories, wound dressings, continence care products, and other skin and catheter-related items. These are everyday care items that help patients manage conditions at home, in hospitals, and in care facilities.

Headquarters
United Kingdom UK
Employees
10 903
IPO date
Oct 26, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
ConvaTec Group PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CTEC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 2CV stock?

The intrinsic value for ConvaTec Group PLC (2CV) under the Base Case is 2.58 EUR.

Is 2CV stock undervalued or overvalued?

Compared with the current market price of 2.84 EUR, the stock appears Overvalued by 9% .

Back to Top